The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
about
Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia.Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoateCost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent.Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013.Evaluation of olanzapine pamoate depot in seriously violent males with schizophrenia in the community.Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical AntipsychoticsBarriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence.Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety.Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.Systematic review of pharmacoeconomic models for schizophrenia
P2860
Q30382281-C001BDE4-D3CB-4C85-9246-8DBF1D47ED1AQ34418847-C6013ADD-94BC-4D5F-ADE2-BC3CCDCEDA45Q35101645-AE21B7FC-191D-456D-97A2-CADCB28FB9DFQ36568895-19B44789-7314-4BE7-A6E8-4692AFAA989AQ36698856-3AE5E492-C9D7-42FB-A2D2-FA5459E154C1Q36738169-76FD0291-E803-45EB-94DC-C2B64D03F4D9Q37006387-96C06C4F-57BB-433C-A315-C9AB4BCDE8E7Q37282220-EC82A758-0034-4C1E-BA80-98709DC11D12Q38223569-D462B79E-A581-4FF3-92BA-2DF35704CD56Q38473914-C78D9FA5-5383-429E-A94C-92CC12B7880FQ38592404-1D319B89-7F73-4F82-9DFB-B3C03A4C19EDQ38675225-F34038C0-4032-4F2F-90B4-332407EBB727Q38851847-49F5781E-68A7-4975-B7E7-A4C3D84AAF82Q39537859-A83408D1-2198-481F-88B4-B41E7BBE5196Q45895632-97B6BA24-B884-4832-B3D0-FA271418DA3BQ47574118-74D982B1-2707-4AC1-BD06-561AFC35386BQ47581504-DBACAD1B-3042-4B3F-8A75-7305CCC75E0FQ54217848-A5531848-9B2F-46A8-BAE7-06E5A49727FCQ57169493-B8584586-4A9E-4446-BAB7-DA70851908DE
P2860
The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The cost effectiveness of long ...... eview of economic evaluations.
@en
type
label
The cost effectiveness of long ...... eview of economic evaluations.
@en
prefLabel
The cost effectiveness of long ...... eview of economic evaluations.
@en
P2860
P1476
The cost effectiveness of long ...... eview of economic evaluations.
@en
P2093
Evanthia Achilla
P2860
P2888
P304
P356
10.1007/S40258-013-0016-2
P50
P577
2013-04-01T00:00:00Z
P6179
1035631941